Sign in

PETMED EXPRESS (PETS)

Q4 2025 Earnings Summary

Reported on Jun 16, 2025
Pre-Earnings Price$3.55Open (Jun 16, 2025)
Post-Earnings Price$3.49Last close (Jun 17, 2025)
Price Change
$-0.06(-1.69%)
MetricYoY ChangeReason

General & Administrative Expenses

-$6M to -$8M

The restatement process reduced previously overstated expenses by $6M–$8M for fiscal 2023, which in turn increased net income in the current period compared to prior periods

Sales Tax Liabilities

Adjustment: $16M to $23M increase

A correction in the accounting approach for sales tax liabilities—shifting from a “probable and estimable” method to recognizing the maximum legal potential liability—resulted in an upward adjustment of $16M–$23M compared to earlier period estimates

Net Income

Increase (implied)

Due to the reduction in general and administrative expenses from the restatement, net income increased in the current period relative to previous periods, demonstrating the effect of correcting historical accounting errors

Revenue and Cash

No change

Despite the restatement adjustments, revenue, cost of goods sold, and cash balances (with cash and equivalents reported at $49.4M) remained unaffected, indicating that the corrections were technical adjustments rather than operational shifts

Research analysts covering PETMED EXPRESS.